Colchicine for Excess ASCVD Risk in IMIDs? Experts Weigh In ...Middle East

Medscape - News
Experts assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic cardiovascular disease (ASCVD) in patients with immune-mediated inflammatory diseases (IMIDs). MDedge News

Hence then, the article about colchicine for excess ascvd risk in imids experts weigh in was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Colchicine for Excess ASCVD Risk in IMIDs? Experts Weigh In )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News